Bonesupport Holding Logo

Bonesupport Holding

ISIN: SE0009858152 | Ticker: BONEX | LEI: 549300COLY053IGTLD63
Sector: Health CareSub-Industry: Health Care Supplies
Country: Sweden

About Bonesupport Holding

Company Description

BONESUPPORT AB is a Scandinavian orthobiologics company that develops and markets CERAMENT®, an innovative range of radiopaque injectable osteoconductive and drug-eluting bioceramic products that have a proven ability to heal defects by remodeling to host bone in six to twelve months.

Our products are effective in treating patients with fractures and bone voids caused by trauma, infection, disease or related surgery.

Year founded

2000

Served area

Europe

Headquarters

Scheelevägen 19, 22370 Lund – Sweden

Financial statements

Download as Excel
Line item in (sek) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Assets N/A 465,218,000.00 343,919,000.00 371,818,000.00
Noncurrent Assets N/A 23,843,000.00 35,443,000.00 33,010,000.00
Property Plant And Equipment N/A 3,163,000.00 4,574,000.00 5,764,000.00
Intangible Assets Other Than Goodwill N/A 8,840,000.00 8,365,000.00 8,384,000.00
Copyrights Patents And Other Industrial Property Rights Service And Operating Rights N/A 2,725,000.00 2,397,000.00 2,075,000.00
Current Assets N/A 441,375,000.00 308,476,000.00 338,808,000.00
Inventories N/A 45,555,000.00 51,762,000.00 56,310,000.00
Finished Goods N/A 14,604,000.00 17,528,000.00 17,867,000.00
Trade And Other Current Receivables N/A 42,083,000.00 50,250,000.00 81,217,000.00
Current Trade Receivables N/A 32,108,000.00 38,413,000.00 62,623,000.00
Current Prepaid Expenses N/A 3,359,000.00 3,219,000.00 4,926,000.00
Other Current Receivables N/A 5,317,000.00 6,126,000.00 7,963,000.00
Cash and cash equivalents 92,065,000.00 353,737,000.00 206,464,000.00 201,281,000.00
Equity And Liabilities N/A 465,218,000.00 343,919,000.00 371,818,000.00
Equity 124,309,000.00 398,899,000.00 265,704,000.00 268,928,000.00
Retained Earnings N/A -1,203,823,000.00 -1,344,494,000.00 -1,344,676,000.00
Share Premium N/A 1,557,639,000.00 1,563,670,000.00 1,563,836,000.00
Liabilities N/A 66,319,000.00 78,215,000.00 102,890,000.00
Noncurrent Liabilities N/A 5,951,000.00 16,515,000.00 12,694,000.00
Noncurrent Provisions N/A 329,000.00 363,000.00 344,000.00
Current Liabilities N/A 60,368,000.00 61,700,000.00 90,196,000.00
Trade And Other Current Payables To Trade Suppliers N/A 12,680,000.00 18,719,000.00 23,571,000.00
Accruals Classified As Current N/A 30,871,000.00 30,183,000.00 54,083,000.00
Current Tax Liabilities Current N/A 4,985,000.00 1,903,000.00 1,097,000.00
Other Current Liabilities N/A 6,974,000.00 5,625,000.00 6,344,000.00
Line item in (sek) 01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue From Sale Of Goods 180,860,000.00 212,885,000.00 328,818,000.00
Revenue From Interest N/A 0.00 811,000.00
Other Income 12,188,000.00 11,308,000.00 43,206,000.00
Profit Loss From Operating Activities -98,561,000.00 -80,669,000.00 -64,535,000.00
Finance Income 5,000.00 0.00 N/A
Finance Costs 445,000.00 1,168,000.00 N/A
Profit Loss Before Tax -99,001,000.00 -81,837,000.00 -64,694,000.00
Income Tax Expense Continuing Operations 2,411,000.00 3,694,000.00 3,473,000.00
Profit (loss) -101,412,000.00 -85,531,000.00 -68,167,000.00
Profit Loss Attributable To Owners Of Parent -101,412,000.00 -85,531,000.00 -68,167,000.00
Line item in (sek) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Profit (loss) N/A -101,412,000.00 -85,531,000.00 -68,167,000.00
Adjustments For Decrease Increase In Inventories N/A -13,202,000.00 -117,000.00 7,077,000.00
Interest Paid Classified As Operating Activities N/A 6,000.00 1,168,000.00 716,000.00
Interest Received Classified As Operating Activities N/A 5,000.00 0.00 811,000.00
Cash Flows From Used In Operating Activities N/A -100,275,000.00 -83,421,000.00 -46,985,000.00
Purchase Of Property Plant And Equipment Classified As Investing Activities N/A 346,000.00 2,608,000.00 1,958,000.00
Purchase Of Intangible Assets Classified As Investing Activities N/A 2,312,000.00 808,000.00 1,321,000.00
Cash Flows From Used In Investing Activities N/A -2,658,000.00 -3,416,000.00 -3,279,000.00
Proceeds From Issuing Shares N/A 378,000,000.00 0.00 N/A
Payments Of Lease Liabilities Classified As Financing Activities N/A 7,768,000.00 5,509,000.00 8,132,000.00
Cash Flows From Used In Financing Activities N/A 365,338,000.00 -61,561,000.00 42,782,000.00
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes N/A 262,405,000.00 -148,398,000.00 -7,482,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents N/A -733,000.00 1,125,000.00 2,299,000.00
Cash and cash equivalents 92,065,000.00 353,737,000.00 206,464,000.00 201,281,000.00

Please note that some sums might not add up.

Filings & Publications

2022

Report
Q1
H1
Q3
FY
Consolidated Report
SWE
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2021

Report
Q1
H1
Q3
FY
Consolidated Report
ENG / SWE
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Date Trading entity / Person Association Trade type Volume
05.03.24 Kristina Ingvar Other Other SEK 0.00
26.07.23 Mary OConnor Other Buy USD 100,792.67
19.05.23 FERGUS MACLEOD Other Sell SEK 1,672,650.00
19.05.23 Lennart Johansson Other Buy SEK 243,760.00
19.05.23 FERGUS MACLEOD Other Buy SEK 204,006.00
19.05.23 FERGUS MACLEOD Other Sell SEK 203,933.40
12.05.23 Annelie Aava Vikner Other Sell SEK 701,220.00
02.05.23 Mary OConnor Other Buy USD 58,507.09
28.04.23 Emil Billbäck Other Sell SEK 14,617,520.00
14.03.23 Kristina Ingvar Other Sell SEK 1,637,634.50

Capital markets information

ISIN

SE0009858152

LEI

549300COLY053IGTLD63

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Sub-Industry

Health Care Supplies

Listed Stock Exchange

Nasdaq Stockholm

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.